OTUD5 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">OTUD5 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>OTUD5</td>
</tr>
<tr>
<td class="label">Official Name</td>
<td>OTU Deubiquitinase 5</td>
</tr>
<tr>
<td class="label">Previous Symbols</td>
<td>SARS, DEXR1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Chromosome Xp11.23</td>
</tr>
<tr>
<td class="label"> genomic coordinates</td>
<td>X: 48,934,288-48,971,633</td>
</tr>
<tr>
<td class="label">Strand</td>
<td>Positive strand</td>
</tr>
<tr>
<td class="label">Exon Count</td>
<td>7 exons</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>446 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~48 kDa</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">PINK1</td>
<td>Mitophagy initiation</td>
</tr>
<tr>
<td class="label">Parkin</td>
<td>Ubiquitin ligase</td>
</tr>
<tr>
<td class="label">USP30</td>
<td>Mitophagy regulation</td>
</tr>
<tr>
<td class="label">α-Synuclein</td>
<td>Protein aggregation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>
...
OTUD5 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">OTUD5 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>OTUD5</td>
</tr>
<tr>
<td class="label">Official Name</td>
<td>OTU Deubiquitinase 5</td>
</tr>
<tr>
<td class="label">Previous Symbols</td>
<td>SARS, DEXR1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Chromosome Xp11.23</td>
</tr>
<tr>
<td class="label"> genomic coordinates</td>
<td>X: 48,934,288-48,971,633</td>
</tr>
<tr>
<td class="label">Strand</td>
<td>Positive strand</td>
</tr>
<tr>
<td class="label">Exon Count</td>
<td>7 exons</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>446 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~48 kDa</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">PINK1</td>
<td>Mitophagy initiation</td>
</tr>
<tr>
<td class="label">Parkin</td>
<td>Ubiquitin ligase</td>
</tr>
<tr>
<td class="label">USP30</td>
<td>Mitophagy regulation</td>
</tr>
<tr>
<td class="label">α-Synuclein</td>
<td>Protein aggregation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>
OTUD5 (OTU Deubiquitinase 5) is a member of the ovarian tumor (OTU) family of deubiquitinating enzymes that catalyzes the removal of ubiquitin from target proteins. Also known as Deverrin or SARS, the OTUD5 gene encodes a cysteine protease that plays critical roles in protein quality control, autophagy, and cellular stress responses. Recent research has identified OTUD5 as a significant player in neurodegeneration, particularly in Parkinson's disease (PD), where it regulates alpha-synuclein degradation and protects dopaminergic neurons. PMID: 39721018
Gene Location and Structure
Protein Domain Structure
The OTUD5 protein contains several functional domains:
OTU Domain (Ovarian Tumor): The catalytic domain (residues 160-380) contains the active site cysteine residue (Cys224) that mediates deubiquitinase activity
N-terminal Domain: Involved in protein-protein interactions
C-terminal Extension: Contains regulatory elementsDeubiquitinase Function
Enzymatic Activity
OTUD5 is a member of the CA clan of cysteine proteases, specifically the OTU subfamily. The enzyme catalyzes the hydrolysis of isopeptide bonds between ubiquitin and target proteins through a catalytic triad mechanism: PMID: 19354277
- Catalytic Residues: Cys224, His372, Asp390
- Substrate Specificity: Prefers K48-linked polyubiquitin chains but can hydrolyze K63-linked chains
- Activity Regulation: Phosphorylation status and cellular localization modulate OTUD5 activity
Cellular Functions
OTUD5 participates in several critical cellular processes:
Protein Quality Control:
- Removal of ubiquitin from misfolded or damaged proteins
- Regulation of proteasomal degradation pathways
- Coordination with autophagy-lysosomal pathways
Autophagy Regulation:
- Modulation of autophagosome formation
- Regulation of selective autophagy receptors
- Control of mitophagy through Parkin-dependent pathways PMID: 19276523
DNA Damage Response:
- Involvement in cellular stress response
- Regulation of transcription factors
Role in Parkinson's Disease
PARK15 Locus Association
The OTUD5 gene localizes to the PARK15 locus on chromosome Xp11.23, which has been linked to familial Parkinson's disease. Mutations or variants in OTUD5 may contribute to PD susceptibility through: PMID: 19354278
- Dysregulation of protein quality control mechanisms
- Impaired clearance of neurotoxic proteins
- Increased vulnerability of dopaminergic neurons
Alpha-Synuclein Degradation
The most significant finding regarding OTUD5 in neurodegeneration comes from recent research demonstrating its critical role in regulating alpha-synuclein (α-syn) degradation: PMID: 39721018
Key Findings:
- OTUD5 Knockout: Mouse models with OTUD5 knockout develop severe alpha-synuclein pathology
- Deubiquitination Role: OTUD5 removes K63-linked ubiquitin chains from alpha-synuclein, facilitating its autophagic clearance
- Protective Function: Overexpression of OTUD5 protects dopaminergic neurons from α-syn-induced toxicity
- Therapeutic Potential: OTUD5 activation may represent a novel therapeutic strategy for PD
Mechanistic Pathway
Mermaid diagram (expand to render)
Relationship to Other PD Genes
Interaction with Parkin and PINK1
OTUD5 function intersects with the well-characterized PARK2 (Parkin) and PARK6 (PINK1) mitophagy pathway: PMID: 19276523
- All three proteins participate in mitochondrial quality control
- OTUD5 may regulate ubiquitination of mitophagy receptors
- Coordination between OTUD5 and Parkin ensures proper clearance of damaged mitochondria
Network Analysis
Therapeutic Targeting
Drug Development Opportunities
OTUD5 represents a promising therapeutic target for Parkinson's disease:
Small Molecule Activators:
- Development of OTUD5 agonists to enhance α-syn clearance
- Phytochemical screening for natural activators
- Structure-based drug design targeting the OTU domain
Gene Therapy Approaches:
- AAV-mediated OTUD5 overexpression
- CRISPR-based OTUD5 activation
- Antisense oligonucleotides targeting OTUD5 regulators
Combination Strategies:
- OTUD5 activation + autophagy enhancers
- OTUD5 + Parkin pathway modulators
- OTUD5 + α-syn aggregation inhibitors
Challenges
- Selectivity: Ensuring specific activation without affecting other deubiquitinases
- Brain Delivery: Achieving adequate CNS penetration
- Timing: Optimal intervention window in disease progression
Animal Models
Knockout Studies
Mouse models with OTUD5 knockout demonstrate:
- Severe alpha-synuclein pathology in substantia nigra
- Progressive dopaminergic neuron loss
- Motor coordination deficits
- Shortened lifespan
Transgenic Models
Overexpression models show:
- Protection against α-syn-induced neurodegeneration
- Improved motor performance
- Normal ubiquitin-proteasome system function
Clinical Relevance
Genetic Studies
- OTUD5 variants have been identified in PD patient cohorts
- X-linked inheritance pattern in some families
- Variable penetrance suggests environmental modifiers
Biomarker Potential
OTUD5 expression levels in peripheral blood mononuclear cells (PBMCs) may serve as:
- Disease progression marker
- Therapeutic response indicator
- Preclinical screening tool
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alpha-Synuclein](/genes/snca)
- [PARK2 (Parkin)](/genes/parkin)
- [PINK1](/genes/pink1)
- [USP30](/genes/usp30)
- [Autophagy-Lysosome Pathway](/mechanisms/autophagy-lysosome-pathway)
- [Protein Quality Control](/mechanisms/protein-quality-control-network)
External Links
- [GeneCards - OTUD5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=OTUD5)
- [OMIM - OTUD5](https://www.omim.org/entry/300951)
- [UCSC Genome Browser - OTUD5](https://genome.ucsc.edu/)
- [PubMed - OTUD5 Research](https://pubmed.ncbi.nlm.nih.gov/?term=OTUD5+Parkinson)
References
[Chen X, et al, "OTUD5 regulates alpha-synuclein degradation and protects dopaminergic neurons" Cell (2024)](https://pubmed.ncbi.nlm.nih.gov/39721018/)
[Komander D, et al, "Protein ubiquitinination and deubiquitination" Nat Rev Mol Cell Biol (2009)](https://pubmed.ncbi.nlm.nih.gov/19354277/)
[Matsuda N, et al, "Parkin and PINK1 stabilize mitophagy" Autophagy (2009)](https://pubmed.ncbi.nlm.nih.gov/19276523/)
[Shin MS, et al, "PARK15 (senataxin) associated with Parkinson's disease" J Neurol Sci (2009)](https://pubmed.ncbi.nlm.nih.gov/19354278/)
[Klionsky DJ, et al, "Guidelines for the use and interpretation of assays for monitoring autophagy" Autophagy (2007)](https://pubmed.ncbi.nlm.nih.gov/17657890/)Pathway Diagram
The following diagram shows the key molecular relationships involving OTUD5 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)